Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
0% of patients receiving placebo
In the past, weight loss medications didnt produce dramatic weight loss, so a very low percentage of patients who might have benefited used them, Low Wang said
Patients who already have insurance coverage for Ozempic or Wegovy may also find semaglutide to be the more practical choice
Why switch from semaglutide to tirzepatide Here are a few reasons you should switch from semaglutide to tirzepatide: More significant weight loss with tirzepatide Clinical trial data show that tirzepatide is more effective for chronic weight management than semaglutide
Unlike Ozempic, which is FDA approved to treat Type 2 diabetes, Wegovy is approved for weight loss in patients with a body mass index (BMI) of 30 or higher and in patients with a BMI of 27 or higher who also have a weight-related medical condition like Type 2 diabetes, high blood pressure, or high cholesterol
US$ 20.54
US$ 23.06
US$ 21.12
US$ 26.72
